Kosan Biosciences Inc - Termination of Registration of a Class of Security under Section 12(g) (15-12G)
26 Juin 2008 - 10:34PM
Edgar (US Regulatory)
UNITED
STATES
|
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
|
|
|
|
|
FORM 15
|
|
CERTIFICATION AND NOTICE OF TERMINATION OF
REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR
SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
.
Commission
File Number
000-31633
Kosan Biosciences Incorporated
(Exact
name of registrant as specified in its charter)
3832 Bay Center Place, Hayward, CA 94545 (510) 732-8400
(Address,
including zip code, and telephone number, including area code, of registrants
principal executive offices)
Common Stock, $0.001 par value
(Title
of each class of securities covered by this Form)
None
(Titles
of all other classes of securities for which a duty to file reports under
section 13(a) or 15(d) remains)
Please
place an X in the box(es) to designate the appropriate rule provision(s) relied
upon to terminate or suspend the duty to file reports:
|
Rule 12g-4(a)(1)(i)
|
x
|
|
Rule 12h-3(b)(1)(i)
|
x
|
|
|
Rule 12g-4(a)(1)(ii)
|
o
|
|
Rule 12h-3(b)(1)(ii)
|
o
|
|
|
Rule 12g-4(a)(2)(i)
|
o
|
|
Rule 12h-3(b)(2)(i)
|
o
|
|
|
Rule 12g-4(a)(2)(ii)
|
o
|
|
Rule 12h-3(b)(2)(ii)
|
o
|
|
|
|
|
|
Rule 15d-6
|
o
|
|
Approximate
number of holders of record as of the certification or notice date: One
Pursuant
to the requirements of the Securities Exchange Act of 1934, Kosan Biosciences
Incorporated has caused this certification/notice to be signed on its behalf by
the undersigned duly authorized person.
|
|
|
Kosan Biosciences Incorporated
|
|
|
|
|
|
|
|
Date:
|
June 26, 2008
|
|
By:
|
/s/ Jeremy Levin
|
|
|
|
|
Name:
|
Jeremy Levin
|
|
|
|
|
Title:
|
President
|
|
Instruction: This form
is required by Rules 12g-4, 12h-3 and 15d-6 of the General Rules and
Regulations under the Securities Exchange Act of 1934. The registrant shall
file with the Commission three copies of Form 15, one of which shall be
manually signed. It may be signed by an officer of the registrant, by counsel
or by any other duly authorized person. The name and title of the person
signing the form shall be typed or printed under the signature.
SEC
2069 (12-04)
|
|
Persons
who respond to the collection of information contained in this form are not
required to respond unless the form displays a currently valid OMB control
number.
|
Kosan Biosciences (MM) (NASDAQ:KOSN)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Kosan Biosciences (MM) (NASDAQ:KOSN)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024
Real-Time news about Kosan Biosciences (MM) (NASDAQ): 0 recent articles
Plus d'articles sur Kosan Biosciences Inc